Also targeting endothelial activation by Icam-1 KO was shown to prevent TAC-induced diastolic and systolic dysfunction (Salvador et al., 2016), this was associated with decreased inflammation and fibrosis. The gene discussed is ICAM1; the disease is persistent truncus arteriosus.